Abstract:Objective To investigate the prognostic value of serum cycliphilin A(CypA) combined with apoptosis repressor with caspase recruitment domain (Arc) level in patients with severe traumatic brain injury (STBI). Methods A total of 140 patients with STBI were selected from March 2018 to December 2020. According to the results of glasgow coma scale (GCS), the patients were divided into poor prognosis group (110 cases) and good prognosis group (30 cases). Basic data of patients, including gender, age, height, body mass index, vital signs, reasons for treatment, in-hospital cardiopulmonary resuscitation (CPR), intubation ratio, etc., as well as their first clinical examination results within 24 hours were collected. The differences of parameters between the two groups were compared, univariate and multivariate analyses were performed to evaluate the predictive value of influencing factors on the prognosis of STBI patients. Results The differences in systolic blood pressure, diastolic blood pressure, in-hospital intubation, in-hospital CPR, thrombin time, plasma prothrombin time, CypA and Arc levels between the two groups were statistically significant (P<0.05). Multivariate analysis showed that CypA and Arc were risk factors for poor prognosis in STBI patients (P<0.05). Spearman analysis was used to analyze the correlation between CypA and Arc and prognosis, and the results showed that CypA and Arc were positively correlated with prognosis (r=0.512, P<0.001; r=0.602, P<0.001). Defining the poor prognosis group as 1 and the good prognosis group as 0, receiver operating characteristic (ROC) curve was used to evaluate the efficacy of CypA and Arc expression levels in prognostic evaluation of STBI patients. The results showed that the area under the curve (AUC) of CypA expression level in STBI patients was 0.858 (95%CI:0.810~0.905, P<0.001), and the AUC of expression level of Arc was 0.839 (95%CI:0.785~0.894, P<0.001), the combined predictive AUC was 0.971 (95%CI:0.949~0.992, P<0.001), respectively. Conclusion Serum CypA combined with Arc level has certain predictive value for the prognosis of STBI patients.